68 related articles for article (PubMed ID: 3937926)
1. [Reduction of the development of monocrotaline-induced pulmonary hypertension in rats by artificial unilateral pneumothorax].
Sugita T; Sawada A; Kuriyama T; Yamagishi F; Kohchi F; Naitoh T; Kakusaka I; Okada O; Watanabe S; Ogata T
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1328-36. PubMed ID: 3937926
[No Abstract] [Full Text] [Related]
2. [Monocrotaline-induced pulmonary hypertension with special reference to the influence of dose, age, and sex].
Sawada A; Kuriyama T; Sugita T; Watanabe S
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 May; 23(5):578-83. PubMed ID: 3932735
[No Abstract] [Full Text] [Related]
3. [The mechanism of the development of pulmonary hypertension induced by monocrotaline in rats].
Kataoka R; Tobise K
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 May; 25(5):563-73. PubMed ID: 3118089
[No Abstract] [Full Text] [Related]
4. [Morphological study of monocrotaline-induced pulmonary hypertension in rats].
Nakashima M
Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Mar; 21(3):227-39. PubMed ID: 6415328
[No Abstract] [Full Text] [Related]
5. [Mast cell hyperplasia in monocrotaline-induced pulmonary changes in rats].
Kuriyama T; Sawada A; Sugita T; Watanabe S; Shen SY; Hiroshima K; Hayashi Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Aug; 23(8):865-72. PubMed ID: 3935842
[No Abstract] [Full Text] [Related]
6. [Pulmonary circulatory disturbance due to pulmonary peripheral lesions--etiology of experimental pulmonary hypertension and cor pulmonale].
Watanabe S
Kokyu To Junkan; 1981 May; 29(5):481-5. PubMed ID: 6797009
[No Abstract] [Full Text] [Related]
7. [Pathophysiological study on monocrotaline-induced pulmonary hypertension in rats (author's transl].
Kido M
Fukuoka Igaku Zasshi; 1981 Mar; 72(3):117-30. PubMed ID: 6790398
[No Abstract] [Full Text] [Related]
8. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
Hilliker KS; Bell TG; Roth RA
Thromb Haemost; 1983 Dec; 50(4):844-7. PubMed ID: 6665765
[TBL] [Abstract][Full Text] [Related]
9. Experimental study on monocrotaline induced pulmonary hypertensive rats. (1) Effect of long-term injection of immunosuppressant.
Tanabe T; Furuya H; Kanemoto N; Goto Y; Hata J
Tokai J Exp Clin Med; 1981 Jan; 6(1):41-8. PubMed ID: 6789505
[TBL] [Abstract][Full Text] [Related]
10. [Effect of hydralazine on the pulmonary arterial hypertension in monocrotaline induced cor pulmonale in Macacus rhesus].
Sun BT
Zhonghua Jie He He Hu Xi Za Zhi; 1987 Aug; 10(4):229-30, 255, 15. PubMed ID: 3125990
[No Abstract] [Full Text] [Related]
11. [Experimental pulmonary hypertension--with special reference to physiopathology and etiology of pulmonary hypertension caused by monocrotaline].
Watanabe S
Kokyu To Junkan; 1979 Jan; 27(1):4-11. PubMed ID: 482744
[No Abstract] [Full Text] [Related]
12. Elevated serum copper concentration in monocrotaline pyrrole treated rats with pulmonary hypertension.
Ganey PE; Roth RA
Biochem Pharmacol; 1987 Oct; 36(20):3535-7. PubMed ID: 3675611
[No Abstract] [Full Text] [Related]
13. Pulmonary peptides, norepinephrine and endocrine cells in monocrotaline pulmonary hypertension.
O'Neill D; Ferrari R; Ceconi C; Rodella A; Smith P; Harris P; Heath D
Cardioscience; 1991 Mar; 2(1):27-33. PubMed ID: 1832315
[TBL] [Abstract][Full Text] [Related]
14. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
[TBL] [Abstract][Full Text] [Related]
15. Effects of single-lung transplantation on chemically induced pulmonary hypertension in the rat.
Kawaguchi AT; Mizuta T; Matsuda H; Shirakura R; Nakahara K; Tanaka H; Kawashima Y
Transplant Proc; 1991 Feb; 23(1 Pt 2):1220-1. PubMed ID: 1824891
[No Abstract] [Full Text] [Related]
16. [Preventive effects of tetrandrine on pulmonary hypertension and right ventricular hypertrophy in rats induced by monocrotaline].
Jin X; Zhang X; Xing J; Liu K; Wang H
Zhongguo Zhong Yao Za Zhi; 1996 Dec; 21(12):751-2, 763. PubMed ID: 9812685
[TBL] [Abstract][Full Text] [Related]
17. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Liu H; Liu ZY; Guan Q
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
[TBL] [Abstract][Full Text] [Related]
18. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
[TBL] [Abstract][Full Text] [Related]
19. Endocardial fibrosis associated with monocrotaline-induced pulmonary hypertension in nonhuman primates (Macaca arctoides).
Chesney CF; Allen JR
Am J Vet Res; 1973 Dec; 34(12):1577-81. PubMed ID: 4271643
[No Abstract] [Full Text] [Related]
20. Pulmonary vascular responses induced by the pyrrolizidine alkaloid, monocrotaline, in rats.
Shubat PJ; Banner W; Huxtable RJ
Toxicon; 1987; 25(9):995-1002. PubMed ID: 3124302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
